Alphamab Oncology (HKG:9966)

Alphamab Oncology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,112	1,086	1,069	803.31	185.32
Short-Term Investments	459.35	321.25	247.86	1,128	1,835
Trading Asset Securities	-	-	33.33	54.01	43.53
Cash & Short-Term Investments	1,571	1,407	1,350	1,985	2,064
Cash Growth	11.67%	4.21%	-31.99%	-3.82%	-13.36%
Accounts Receivable	20.3	7.13	15.49	7.61	-
Other Receivables	37.77	65.42	64.03	59.92	84.8
Receivables	58.07	72.55	79.52	67.53	84.8
Inventory	81.81	78.75	64.64	57.91	44.32
Other Current Assets	-	-	-	5.63	5.86
Total Current Assets	1,711	1,559	1,495	2,117	2,199
Property, Plant & Equipment	524.01	576.95	619.74	530.52	393.02
Other Long-Term Assets	6.4	1.63	3.26	58.02	47.27
Total Assets	2,242	2,137	2,118	2,705	2,640
Accounts Payable	42.29	31.54	17.63	28.48	5.28
Accrued Expenses	118.93	119.89	135.36	109.04	77.61
Current Portion of Long-Term Debt	52.26	75	175	449.99	188
Current Portion of Leases	2.44	5.5	15.11	13.82	10.15
Current Unearned Revenue	15.48	6.86	13.07	6.38	5.69
Other Current Liabilities	22.64	28.05	28.74	29.55	42.82
Total Current Liabilities	254.04	266.84	384.91	637.26	329.54
Long-Term Debt	129.98	175	150	153.83	21.35
Long-Term Leases	1.27	1.58	5.28	19.63	3.31
Long-Term Unearned Revenue	24.57	21.58	19.67	24.09	12.24
Total Liabilities	409.87	465	559.86	834.8	366.44
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	4,055	4,053	3,726	3,717	3,713
Retained Earnings	-2,177	-2,343	-2,132	-1,807	-1,394
Treasury Stock	-9.19	-	-	-	-
Comprehensive Income & Other	-37.43	-37.64	-35.85	-39.84	-45.45
Total Common Equity	1,832	1,672	1,558	1,870	2,273
Shareholders' Equity	1,832	1,672	1,558	1,870	2,273
Total Liabilities & Equity	2,242	2,137	2,118	2,705	2,640
Total Debt	185.96	257.08	345.39	637.27	222.81
Net Cash (Debt)	1,386	1,150	1,005	1,348	1,841
Net Cash Growth	20.46%	14.45%	-25.46%	-26.78%	-13.52%
Net Cash Per Share	1.41	1.20	1.07	1.44	1.98
Filing Date Shares Outstanding	961.97	964.84	939.72	934.94	934.94
Total Common Shares Outstanding	961.97	964.84	939.72	934.94	934.94
Working Capital	1,457	1,292	1,110	1,479	1,870
Book Value Per Share	1.90	1.73	1.66	2.00	2.43
Tangible Book Value	1,832	1,672	1,558	1,870	2,273
Tangible Book Value Per Share	1.90	1.73	1.66	2.00	2.43
Buildings	298.2	303.51	285.28	227.4	237.74
Machinery	397.62	384.82	286.3	152.46	120.65
Construction In Progress	7.41	0.89	90.83	143.08	23.42
Leasehold Improvements	6.26	6.26	6.75	1.9	0.41

Source: S&P Global Market Intelligence. Standard template. Financial Sources.